Physician profile
Cassandra E Schmidt
NPI 1881085256
$1,113.43
in general payments reported to CMS, 2019-2025
16 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.75 · 2022: $184 · 2023: $355 · 2024: $300 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $192.48 | 2023-2024 | Repatha, Otezla |
| Exact Sciences Corporation | $177.80 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $171.08 | 2022-2025 | Mounjaro, Jardiance |
| Abbvie INC. | $139.46 | 2022-2025 | |
| Gilead Sciences, INC. | $107.34 | 2021-2024 | Epclusa |
| Novo Nordisk INC | $59.10 | 2023 | Ozempic, Rybelsus |
| Pfizer INC. | $53.42 | 2025 | |
| Organon LLC | $36.57 | 2023-2024 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $32.61 | 2025 | Farxiga, Airsupra |
| Axsome Therapeutics, INC. | $24.32 | 2025 | Symbravo |
| Glaxosmithkline, LLC. | $23.43 | 2022 | |
| Tris Pharma INC | $23.22 | 2025 | Dyanavel Xr |
| Sanofi Pasteur INC. | $22.51 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.93 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $17.88 | 2025 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.28 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.